Company Filing History:
Years Active: 2009-2010
Title: Paul Hughes: Innovator in Neural Regeneration
Introduction
Paul Hughes is a prominent inventor based in Auckland, New Zealand. He has made significant contributions to the field of neural regeneration, focusing on innovative methods and compounds that promote neuronal health and recovery. With a total of 2 patents, Hughes is dedicated to advancing treatments for neural injuries and degenerative diseases.
Latest Patents
Hughes' latest patents include groundbreaking inventions related to neural regeneration peptides. The first patent, titled "Neural regeneration peptides and methods for their use in treatment of neural injury or degeneration," discloses a family of neuronal migration-inducing, proliferation-promoting, and neurite outgrowth-promoting factors known as NRP compounds. These compounds provide compositions and methods for treating brain injuries and neurodegenerative diseases. NRP compounds are designed to induce neurons and neuroblasts to proliferate and migrate into damaged areas caused by conditions such as stroke, trauma, and metabolic disorders. They can be administered through various means, including orally and directly into the nervous system.
The second patent, "Neural regeneration peptides and methods for their use in treatment of brain damage," also focuses on NRP compounds. This invention promotes neuronal migration, neurite outgrowth, neuronal proliferation, and survival. Similar to the first patent, it provides methods for treating brain injuries and neurodegenerative diseases. NRP compounds can be formulated into pharmaceutically acceptable dose forms for therapeutic use, and methods for detecting neural regeneration and proliferation can help develop other neurally active agents.
Career Highlights
Hughes is currently associated with Neuren Pharmaceuticals Limited, a company dedicated to developing innovative treatments for neurological conditions. His work has positioned him as a key figure in the field of neural regeneration, contributing to advancements that could significantly improve patient outcomes.
Collaborations
Hughes collaborates with notable colleagues, including Frank Sieg and Thorsten Gorba. Their combined expertise enhances the research and development efforts at Neuren Pharmaceuticals Limited.
Conclusion
Paul Hughes is a visionary inventor whose work in neural regeneration has the potential to transform treatments for brain injuries and neurodegenerative diseases. His innovative patents and collaborations reflect a commitment to improving neurological health and advancing medical science.